Pneumococcal conjugate second or third-dose vaccines (PCVc) in Botswana
Botswana: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 95.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Botswana, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Botswana is 95.0%, measured in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 6.7% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Botswana peaked at 95.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Botswana 38th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Botswana, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 52.0% | — |
| 2013 | 65.0% | +25.0% |
| 2014 | 82.0% | +26.2% |
| 2015 | 89.0% | +8.5% |
| 2016 | 95.0% | +6.7% |
| 2017 | 95.0% | +0.0% |
| 2018 | 95.0% | +0.0% |
| 2019 | 95.0% | +0.0% |
| 2020 | 95.0% | +0.0% |
| 2021 | 95.0% | +0.0% |
| 2022 | 74.0% | -22.1% |
| 2023 | 79.0% | +6.8% |
| 2024 | 95.0% | +20.3% |
| 2025 | 95.0% | +0.0% |
Botswana compared with similar countries
- Botswana's 95.0% is above the median for upper middle income countries, which is 76.0%, 1.2× the median. (57 countries reporting)
- Botswana's 95.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 66.8% | 0.0% | 95.0% | 10 |
| 2020s | 88.8% | 74.0% | 95.0% | 6 |
Countries ranked near Botswana
More health data for Botswana
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2265 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,150 deaths per 1,000 people (2090)
- Number of infants who die before age 1 281 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.6484 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0579 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Botswana?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Botswana was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Botswana?
- The highest recorded value was 95.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Botswana?
- The lowest recorded value was 0.0% in 2008.
- How does Botswana rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Botswana ranks 38th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Botswana?
- Over the last ten years it is up 6.7%. The long-run trend across the full record is volatile.
- Where does this Botswana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).